Investigation of the eIF2alpha phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells. [electronic resource]
Producer: 20101217Description: 859-66 p. digitalISSN:- 0026-8984
- Benzhydryl Compounds -- pharmacology
- Boronic Acids -- pharmacology
- Bortezomib
- Breast Neoplasms -- metabolism
- Cell Line, Tumor
- Cysteine Proteinase Inhibitors -- pharmacology
- Enzyme Activation -- drug effects
- Eukaryotic Initiation Factor-2 -- metabolism
- Female
- HSP70 Heat-Shock Proteins -- antagonists & inhibitors
- Heme Oxygenase-1 -- antagonists & inhibitors
- Humans
- Leupeptins -- pharmacology
- Melanoma -- metabolism
- Neoplasm Proteins -- antagonists & inhibitors
- Phosphorylation -- drug effects
- Proteasome Endopeptidase Complex -- metabolism
- Proteasome Inhibitors
- Protein Kinase C -- metabolism
- Protoporphyrins -- pharmacology
- Pyrazines -- pharmacology
- Pyrrolidinones -- pharmacology
- eIF-2 Kinase -- metabolism
- p38 Mitogen-Activated Protein Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.